Credit Suisse Maintains Neutral on Incyte, Lowers Price Target to $86

Credit Suisse analyst Evan Seigerman maintains Incyte (NASDAQ:INCY) with a Neutral and lowers the price target from $90 to $86.

Benzinga · 01/03/2020 14:07

Credit Suisse analyst Evan Seigerman maintains Incyte (NASDAQ:INCY) with a Neutral and lowers the price target from $90 to $86.